Different Multivariable Risk Factors for Rapid Progressive Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis and Anti-Synthetase Syndrome

Yu Zuo,Lifang Ye,Fang Chen,Yawen Shen,Xin Lu,Guochun Wang,Xiaoming Shu
DOI: https://doi.org/10.3389/fimmu.2022.845988
IF: 7.3
2022-03-07
Frontiers in Immunology
Abstract:Background Interstitial lung disease (ILD) is frequently observed in anti-melanoma differentiation-associated protein 5 (MDA5) antibody positive dermatomyositis (DM) and anti-synthetase syndrome (ASS), where they often develop a rapidly progressive ILD (RP-ILD) leading to poor prognosis. Objective The aim of this study was to construct multivariable prediction risk factors for rapid progressive ILD (RP-ILD) in anti-MDA5 positive DM (MDA5 + DM) and ASS. Methods 333 idiopathic inflammatory myopathy (IIM) associated ILD patients were studied retrospectively. Risk factors for RP-ILD in MDA5 + DM and ASS patients were identified by univariate and multivariable logistic regression analysis. The mortality was assessed using Kaplan-Meier analysis. Results RP-ILD was more prevalent in MDA5 + DM patients than ASS patients. MDA5 + DM patients with RP-ILD had significantly lower survival rates than those in ASS patients. The independent risk factors for RP-ILD in MDA5 + DM patients were fever (OR 3.67, 95% CI:1.79-7.52), lymphopenia (OR 2.14, 95% CI:1.01-4.53), especially decreased levels of CD3 + T cells (OR 2.56, 95% CI:1.17-5.61), decreased levels of CD3 + CD4 + T cells (OR 2.80, 95% CI:1.37-5.73), CD3 + CD8 + T cells (OR 2.18, 95% CI:1.05-4.50), elevated CD5 - CD19 + B cells (OR 3.17, 95% CI:1.41-7.13), elevated ALT (OR 2.36, 95% CI:1.15-4.81), high lactate dehydrogenase (LDH) (OR 3.08, 95% CI:1.52-6.27), hyper-ferritin (OR 4.97, 95% CI:1.97-12.50), elevated CEA (OR 2.28, 95% CI:1.13-4.59), and elevated CA153 (OR 3.31, 95% CI:1.50-7.27). While the independent risk factors for RP-ILD in ASS patients were elevated CEA (OR 5.25, 95% CI: 1.73-15.93), CA125 (OR 2.79, 95% CI: 1.10-7.11) and NSE (OR 4.86, 95% CI: 1.44-16.37). Importantly, serum ferritin>2200ng/ml predicted patient’s death within half a year in MDA5 + DM patients with RP-ILD, but not in ASS patients. Conclusions There were significant different mortality and multivariable risk factors for RP-ILD in MDA5 + DM patients and ASS patients. Potential clinical benefits of using these different risk factors deserve assessment of severity and prognosis in IIM patients.
immunology
What problem does this paper attempt to address?